High-affinity immunoglobulin E receptor (FcεRI) (FcεRI)

The high-affinity immunoglobulin E receptor (FcεRI) complexed with venom-specific IgE is the central molecular assembly responsible for triggering immediate hypersensitivity reactions to insect venom. This receptor is primarily expressed as a tetramer (αβγ2) on mast cells and basophils, where it binds the Fc portion of IgE antibodies with extremely high affinity (UniProt: P12319). In individuals sensitized to Hymenoptera venom, the receptor is loaded with venom-specific IgE; upon subsequent exposure, venom allergens cross-link these IgE-FcεRI complexes, initiating an intracellular signaling cascade that leads to the rapid release of inflammatory mediators like histamine, proteases, and leukotrienes (PMID: 21920481). This process can result in clinical symptoms ranging from localized swelling to life-threatening systemic anaphylaxis. Therapeutic strategies focus on either neutralizing circulating IgE to prevent receptor loading, as seen with the monoclonal antibody Omalizumab, or modulating the immune system through Venom Immunotherapy (VIT) to favor the production of IgG4 blocking antibodies that intercept allergens before they can activate the receptor (PMID: 30243458).

Other names

Fc epsilon RIHigh affinity IgE receptorIgE-FcεRI complexFCER1FceRI

Anti-IgE monoclonal antibodies like Omalizumab bind to the Cε3 domain of free IgE, preventing its interaction with the FcεRI receptor on mast cells and basophils (PMID: 24565708). Venom Immunotherapy (VIT) induces the production of allergen-specific IgG4 'blocking' antibodies that compete with IgE for venom allergen binding, thereby preventing the cross-linking of IgE-FcεRI complexes (PMID: 30243458).